| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.29 | 0.02 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |